A microRNA signature for risk-stratification and response prediction to FOLFOX-based adjuvant therapy in stage II and III colorectal cancer

The present work was supported by the CA72851, CA181572, CA184792, and CA187956 grants from the National Cancer Institute, National Institute of Health; RP140784 from the Cancer Prevention Research Institute of Texas; grants from the Sammons Cancer Center and Baylor Foundation, as well as funds from...

Full description

Bibliographic Details
Authors: Okuno, Keisuke, Kandimalla, Raju, Mendiola, Marta, Balaguer, Francesc, Bujanda Fernández de Pierola, Luis, Fernández Martos, Carlos, Aparicio, Jorge, Feliú, Jaime, Tokunaga, Masanori, Kinugasa, Yusuke, Maurel, Joan, Goel, Ajay
Format: article
Publication Date:2023
Country:España
Institution:Universidad del País Vasco
Repository:Addi. Archivo Digital para la Docencia y la Investigación
OAI Identifier:oai:addi.ehu.eus:10810/59988
Online Access:http://hdl.handle.net/10810/59988
Access Level:Open access
Keyword:colorectal cancer
microRNA
predictive biomarker
adjuvant chemotherapy
FOLFOX
Description
Summary:The present work was supported by the CA72851, CA181572, CA184792, and CA187956 grants from the National Cancer Institute, National Institute of Health; RP140784 from the Cancer Prevention Research Institute of Texas; grants from the Sammons Cancer Center and Baylor Foundation, as well as funds from the Baylor Research Institute, Dallas, TX, USA awarded to Ajay Goel. The present work was also supported by Catalan Agency for Management of University and Research Grants (AGAUR) (2014-SGR-474 and 2017-SGR-1174), Fundació la Marató de TV3 (201330.10), Instituto de Salud Carlos III (PI13/01728 and PI19/00740) and Fundacion Olga Torres (Modalitat A. 2019/2020) to Joan Maurel.

Similar Items